• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI影像组学模型预测直肠癌放化疗后的病理完全缓解情况。

MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.

作者信息

Shin Jaeseung, Seo Nieun, Baek Song-Ee, Son Nak-Hoon, Lim Joon Seok, Kim Nam Kyu, Koom Woong Sub, Kim Sungwon

机构信息

From the Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea (J.S., N.S., S.E.B., J.S.L., S.K.); Data Science Team, Center for Digital Health, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea (N.H.S.); and Departments of Surgical Oncology (N.K.K.) and Radiation Oncology (W.S.K.), Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Radiology. 2022 May;303(2):351-358. doi: 10.1148/radiol.211986. Epub 2022 Feb 8.

DOI:10.1148/radiol.211986
PMID:35133200
Abstract

Background Preoperative assessment of pathologic complete response (pCR) in locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotherapy (nCRT) is increasingly needed for organ preservation, but large-scale validation of an MRI radiomics model remains lacking. Purpose To evaluate radiomics models based on T2-weighted imaging and diffusion-weighted MRI for predicting pCR after nCRT in LARC and compare their performance with visual assessment by radiologists. Materials and Methods This retrospective study included patients with LARC (clinical stage T3 or higher, positive nodal status, or both) who underwent post-nCRT MRI and elective resection between January 2009 and December 2018. Surgical histopathologic analysis was the reference standard for pCR. Radiomic features were extracted from the volume of interest on T2-weighted images and apparent diffusion coefficient (ADC) maps from post-nCRT MRI to generate three models: T2 weighted, ADC, and both T2 weighted and ADC (merged). Radiomics signatures were generated using the least absolute shrinkage and selection operator with tenfold cross-validation. Three experienced radiologists independently rated tumor regression grades at MRI and compared these with the radiomics models' diagnostic outcomes. Areas under the curve (AUCs) of the radiomics models and pooled readers were compared by using the DeLong method. Results Among 898 patients, 189 (21%) achieved pCR. The patients were chronologically divided into training ( = 592; mean age ± standard deviation, 59 years ± 12; 388 men) and test ( = 306; mean age, 59 years ± 12; 190 men) sets. The radiomics signatures of the T2-weighted, ADC, and merged models demonstrated AUCs of 0.82, 0.79, and 0.82, respectively, with no evidence of a difference found between the T2-weighted and merged models ( = .49), while the ADC model performed worse than the merged model ( = .02). The T2-weighted model had higher classification performance (AUC, 0.82 vs 0.74 [ = .009]) and sensitivity (80.0% vs 15.6% [ < .001]), but lower specificity (68.4% vs 98.6% [ < .001]) than the pooled performance of the three radiologists. Conclusion An MRI-based radiomics model showed better classification performance than experienced radiologists for diagnosing pathologic complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy. © RSNA, 2022 See also the editorial by Taylor in this issue.

摘要

背景 新辅助放化疗(nCRT)后局部晚期直肠癌(LARC)的病理完全缓解(pCR)的术前评估对于器官保留的需求日益增加,但MRI放射组学模型的大规模验证仍然缺乏。目的 评估基于T2加权成像和扩散加权MRI的放射组学模型,以预测LARC患者nCRT后的pCR,并将其性能与放射科医生的视觉评估进行比较。材料与方法 这项回顾性研究纳入了2009年1月至2018年12月期间接受nCRT后MRI检查和择期切除的LARC患者(临床分期为T3或更高、淋巴结阳性或两者皆有)。手术组织病理学分析是pCR的参考标准。从nCRT后MRI的T2加权图像和表观扩散系数(ADC)图上的感兴趣体积中提取放射组学特征,以生成三个模型:T2加权、ADC以及T2加权和ADC两者合并(合并)。使用最小绝对收缩和选择算子及十折交叉验证生成放射组学特征。三名经验丰富的放射科医生在MRI上独立评定肿瘤退缩分级,并将其与放射组学模型的诊断结果进行比较。使用DeLong方法比较放射组学模型和汇总读者的曲线下面积(AUC)。结果 在898例患者中,189例(21%)实现了pCR。患者按时间顺序分为训练组(n = 592;平均年龄±标准差,59岁±12岁;388名男性)和测试组(n = 306;平均年龄,59岁±12岁;190名男性)。T2加权、ADC和合并模型的放射组学特征的AUC分别为0.82、0.79和0.82,T2加权模型和合并模型之间未发现差异证据(P = 0.49),而ADC模型的表现比合并模型差(P = 0.02)。T2加权模型比三名放射科医生的汇总表现具有更高的分类性能(AUC,0.82对0.74 [P = 0.009])和敏感性(80.0%对15.6% [P < 0.001]),但特异性较低(68.4%对98.6% [P < 0.001])。结论 基于MRI的放射组学模型在诊断新辅助放化疗后局部晚期直肠癌患者的病理完全缓解方面显示出比经验丰富的放射科医生更好的分类性能。© RSNA,2022 另见本期Taylor的社论。

相似文献

1
MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.MRI影像组学模型预测直肠癌放化疗后的病理完全缓解情况。
Radiology. 2022 May;303(2):351-358. doi: 10.1148/radiol.211986. Epub 2022 Feb 8.
2
[Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].[MRI肿瘤退缩分级与表观扩散系数联合预测局部晚期直肠癌新辅助治疗后病理完全缓解的价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Apr 25;24(4):359-365. doi: 10.3760/cma.j.cn.441530-20200225-00089.
3
MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.MRI 基放射组学模型在预测局部晚期直肠癌新辅助放化疗病理完全缓解方面优于放射科医生。
Acad Radiol. 2023 Sep;30 Suppl 1:S176-S184. doi: 10.1016/j.acra.2022.12.037. Epub 2023 Feb 2.
4
Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.多参数 MRI 的放射组学分析预测局部晚期直肠癌新辅助放化疗的病理完全缓解。
Eur Radiol. 2019 Mar;29(3):1211-1220. doi: 10.1007/s00330-018-5683-9. Epub 2018 Aug 20.
5
Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.选择新辅助放化疗后保留器官策略的候选者:整合 MRI 放射组学和病理组学的模型的开发和验证。
J Magn Reson Imaging. 2022 Oct;56(4):1130-1142. doi: 10.1002/jmri.28108. Epub 2022 Feb 10.
6
MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.基于 MRI 的 delta 放射组学可预测局部晚期直肠癌新辅助放化疗后的病理完全缓解。
Acad Radiol. 2021 Nov;28 Suppl 1:S95-S104. doi: 10.1016/j.acra.2020.10.026. Epub 2020 Nov 12.
7
MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.直肠癌磁共振成像:放射组学分析评估新辅助治疗后的治疗反应。
Radiology. 2018 Jun;287(3):833-843. doi: 10.1148/radiol.2018172300. Epub 2018 Mar 7.
8
MRI radiomics signature to predict lymph node metastasis after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.MRI 放射组学特征预测局部进展期直肠癌新辅助放化疗后淋巴结转移
Abdom Radiol (NY). 2023 Jul;48(7):2270-2283. doi: 10.1007/s00261-023-03910-4. Epub 2023 Apr 21.
9
Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.基于 MRI 的放射组学模型评估直肠癌新辅助放化疗的治疗反应。
BMC Med Imaging. 2021 Feb 16;21(1):30. doi: 10.1186/s12880-021-00560-0.
10
Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI.局部晚期直肠癌的影像组学:基于机器学习利用治疗前矢状位T2加权磁共振成像预测新辅助放化疗疗效
Jpn J Radiol. 2023 Jan;41(1):71-82. doi: 10.1007/s11604-022-01325-7. Epub 2022 Aug 13.

引用本文的文献

1
How best to combine DWI and T2WI to predict pathologic complete response: a multi-center study on interpreting MRI following chemoradiotherapy of rectal cancer.如何最佳地结合弥散加权成像(DWI)和T2加权成像(T2WI)来预测病理完全缓解:一项关于直肠癌放化疗后MRI解读的多中心研究
Eur Radiol. 2025 Aug 15. doi: 10.1007/s00330-025-11927-0.
2
Baseline MRI habitat imaging for predicting treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.用于预测局部晚期直肠癌新辅助放化疗治疗反应的基线MRI栖息地成像
Front Oncol. 2025 Jul 11;15:1551224. doi: 10.3389/fonc.2025.1551224. eCollection 2025.
3
The Impact of Adjuvant Chemotherapy on Clinical Outcomes in Locally Advanced Rectal Cancer: A CHORD Consortium Analysis.
辅助化疗对局部晚期直肠癌临床结局的影响:一项CHORD联盟分析
Curr Oncol. 2025 Jun 26;32(7):371. doi: 10.3390/curroncol32070371.
4
Diffusion-weighted imaging in rectal cancer MRI from theory to practice.直肠癌MRI中的扩散加权成像:从理论到实践
Abdom Radiol (NY). 2025 Jul 11. doi: 10.1007/s00261-025-05102-8.
5
Rectal-RadioSAM: Large model-assisted multi-parametric magnetic resonance imaging pipeline for predicting response to neoadjuvant chemoradiotherapy in rectal cancer without human intervention.直肠-放射性核素显像剂辅助模型:用于预测直肠癌新辅助放化疗反应的大型模型辅助多参数磁共振成像流程,无需人工干预。
Phys Imaging Radiat Oncol. 2025 Jun 20;35:100797. doi: 10.1016/j.phro.2025.100797. eCollection 2025 Jul.
6
MRI-based habitat, intra-, and peritumoral machine learning model for perineural invasion prediction in rectal cancer.基于MRI的直肠癌神经周围侵犯预测的瘤周、瘤内及瘤周机器学习模型。
Abdom Radiol (NY). 2025 Jul 3. doi: 10.1007/s00261-025-05095-4.
7
Clinical characteristics and survival outcomes of rectal cancer patients across different mrT3 substages determined by rectal MRI.经直肠MRI确定的不同mrT3亚分期直肠癌患者的临床特征和生存结局
Int J Colorectal Dis. 2025 Jun 28;40(1):147. doi: 10.1007/s00384-025-04935-5.
8
Can Radiomics Predict Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer? A Systematic Review and Meta-Analysis of Diagnostic-Accuracy Studies.放射组学能否预测直肠癌新辅助放化疗后的病理完全缓解?诊断准确性研究的系统评价和荟萃分析。
J Pers Med. 2025 Jun 10;15(6):244. doi: 10.3390/jpm15060244.
9
Research progress in multimodal radiomics of rectal cancer tumors and peritumoral regions in MRI.直肠癌肿瘤及瘤周区域在MRI中的多模态放射组学研究进展
Abdom Radiol (NY). 2025 May 31. doi: 10.1007/s00261-025-04965-1.
10
A computed tomography-based radiomics prediction model for BRAF mutation status in colorectal cancer.一种基于计算机断层扫描的结直肠癌BRAF突变状态的影像组学预测模型。
Abdom Radiol (NY). 2025 May 15. doi: 10.1007/s00261-025-04983-z.